2022 Regular Session • Florida Legislature
S1574: Prescription Drug Price Transparency
Legislative Summary
Prohibiting permits for prescription drug manufacturers and nonresident prescription drug manufacturers and for certain wholesale distributors of prescription drugs from being renewed unless specified requirements are met; providing reporting requirements for certain entities that engage in wholesale distributions of prescription drugs; providing requirements for notifications by manufacturers of prescription drug price increases under certain circumstances; providing additional requirements for contracts between pharmacy benefit managers and individual health insurers, group health insurers, and health maintenance organizations, respectively, etc.
Bill History
1/6/2022
Filed
Senate
1/12/2022
Referred to Banking and Insurance; Regulated Industries; Appropriations
Senate
1/18/2022
Introduced
Senate
3/12/2022
Indefinitely postponed and withdrawn from consideration
Senate
3/14/2022
Died in Banking and Insurance
Senate
Status Information
Current Status
Failed(3/14/2022)
Chamber
Senate
Sine DiePrior Session
Sponsors
Democrat: 1
Primary Sponsor

Janet Cruz
Democrat